Objective: To evaluate and analyze the effectiveness and the complications of large, porous hydroxyapatite(HA) ocular implants in pediatric patients. Methods: In this retrospective study, 26 cases of pediatric patients 6 to 59 months old, who underwent porous HA orbital unilateral implants between January 2009 and June 2016 at Eye Hospital, Wenzhou Medical University were reviewed. Recorded outcomes included the age, the size of the HA implants, implant-related complications, and the cosmetic satisfaction.Results: The implant diameter sizes were 18 mm (2 patients), 20 mm (9 patients), 21 mm (4 patients),22 mm (9 patients), and 23 mm (2 patients). All patients who underwent the implant procedure were free of complications during the study period. The parents of these patients were satisfied with the final cosmetic appearance. Conclusions: Large sized orbital implants (18- to 23-mm diameter) in pediatric patients between 6 and 59 months of age appear to be safe and effective.
朱秀影,盛文. 儿童大直径义眼座植入疗效[J]. 中华眼视光学与视觉科学杂志, 2017, 19(11): 682-685.
Xiuying Zhu,Wen Sheng. Use of Large Hydroxyapatite Orbital Implants in a Pediatric Population. Chinese Journal of Optometry Ophthalmology and Visual science, 2017, 19(11): 682-685. DOI: 10.3760/cma.j.issn.1674-845X.2017.11.009
Hintschich C, Zonneveld F, Baldeschi L, et al. Bony orbital development after early enucleation in humans. Br J Ophthalmol, 2001,85(2): 205-208. DOI: 10.1136/bjo.85.2.205.
[11]
Anderson RL, Thiese SM, Nerad JA, et al. The universal orbital implant: indications and methods. Adv Ophthalmic Plast Reconstr Surg, 1990, (8): 88-99. PMID: 2248728.
[12]
Dutton JJ. Coralline hydroxyapatite as an ocular implant.Ophthalmology, 1991, 98(3): 370-377. DOI: 10.1016/S0161-6420(91)32304-2.
[13]
Christmas NJ, Van Quill K, Murray TG, et al. Evaluation of efficacy and complications: primary pediatric orbital implants after enucleation. Arch Ophthalmol, 2000, 118(4): 503-506. DOI:10.1001/archopht.118.4.503.
[14]
Quaranta-Leoni FM, Sposato S, Lorenzano D. Secondary orbital ball implants after enucleation and evisceration: surgical management,morbidity, and long-term outcome. Ophthal Plast Reconstr Surg, 2015,31(2): 115-118. DOI: 10.1097/IOP.0000000000000212.
[15]
Sami D, Young S, Petersen R. Perspective on orbital enucleation implants. Surv Ophthalmol, 2007, 52(3): 244-265. DOI: 10.1016/j.survophthal.2007.02.007.
[16]
De Potter P, Shields CL, Shields JA, et al. Use of the hydroxyapatite ocular implant in the pediatric population. Arch Ophthalmol, 1994,112(2): 208-212. DOI: 10.1001/archopht.1994.01090140084028.
[17]
Wang JK, Liao SL, Lin LLK, et al. Porous orbital implants, wraps, and PEG placement in the pediatric population after enucleation. Am J Ophthalmol, 2007, 144(1): 109-116. DOI: 10.1016/j.ajo.2007.03.042.
hydrophilic osmotic expanders(hydrogel)in the reconstruction of congenital clinical anophthalmos. Curr Opin Ophthalmo1, 2004,
Hintschich C, Zonneveld F, Baldeschi L, et al. Bony orbital development after early enucleation in humans. Br J Ophthalmol, 2001,85(2): 205-208. DOI: 10.1136/bjo.85.2.205.
[11]
Anderson RL, Thiese SM, Nerad JA, et al. The universal orbital implant: indications and methods. Adv Ophthalmic Plast Reconstr Surg, 1990, (8): 88-99. PMID: 2248728.
[12]
Dutton JJ. Coralline hydroxyapatite as an ocular implant.Ophthalmology, 1991, 98(3): 370-377. DOI: 10.1016/S0161-6420(91)32304-2.
[13]
Christmas NJ, Van Quill K, Murray TG, et al. Evaluation of efficacy and complications: primary pediatric orbital implants after enucleation. Arch Ophthalmol, 2000, 118(4): 503-506. DOI:10.1001/archopht.118.4.503.
[14]
Quaranta-Leoni FM, Sposato S, Lorenzano D. Secondary orbital ball implants after enucleation and evisceration: surgical management,morbidity, and long-term outcome. Ophthal Plast Reconstr Surg, 2015,31(2): 115-118. DOI: 10.1097/IOP.0000000000000212.
[15]
Sami D, Young S, Petersen R. Perspective on orbital enucleation implants. Surv Ophthalmol, 2007, 52(3): 244-265. DOI: 10.1016/j.survophthal.2007.02.007.
[16]
De Potter P, Shields CL, Shields JA, et al. Use of the hydroxyapatite ocular implant in the pediatric population. Arch Ophthalmol, 1994,112(2): 208-212. DOI: 10.1001/archopht.1994.01090140084028.
[17]
Wang JK, Liao SL, Lin LLK, et al. Porous orbital implants, wraps, and PEG placement in the pediatric population after enucleation. Am J Ophthalmol, 2007, 144(1): 109-116. DOI: 10.1016/j.ajo.2007.03.042.
Quaranta-Leoni FM. Congenital anophthalmia: current concepts in management. Curr Opin Ophthalmol, 2011, 22(5): 380-384.DOI: 10.1097/ICU.0b013e328349948a.
[21]
Hou Z, Yang Q, Chen T, et al. The use of self-inflating hydrogel expanders in pediatric patients with congenital microphthalmia in China. JAAPOS, 2012, 16(5): 458-463. DOI: 10.1016/j.jaapos.2012.07.002.
[22]
Mitchell KT, Hollsten DA, White WL, et al. The autogenous dermis-fat orbital implant in children. J AAPOS, 2001, 5(6): 367-369. DOI: 10.1067/mpa.2001.118870.
[23]
Gundlach KKH, Guthoff RF, Hingst VHM, et al. Expansion of the socket and orbit for congenital clinical anophthalmia. Plast Reconstr Surg, 2005, 116(5): 1214-1222. DOI: 10.1097/01.prs.0000181653.38200.eb.
Quaranta-Leoni FM. Congenital anophthalmia: current concepts in management. Curr Opin Ophthalmol, 2011, 22(5): 380-384.DOI: 10.1097/ICU.0b013e328349948a.
[21]
Hou Z, Yang Q, Chen T, et al. The use of self-inflating hydrogel expanders in pediatric patients with congenital microphthalmia in China. JAAPOS, 2012, 16(5): 458-463. DOI: 10.1016/j.jaapos.2012.07.002.
[22]
Mitchell KT, Hollsten DA, White WL, et al. The autogenous dermis-fat orbital implant in children. J AAPOS, 2001, 5(6): 367-369. DOI: 10.1067/mpa.2001.118870.
[23]
Gundlach KKH, Guthoff RF, Hingst VHM, et al. Expansion of the socket and orbit for congenital clinical anophthalmia. Plast Reconstr Surg, 2005, 116(5): 1214-1222. DOI: 10.1097/01.prs.0000181653.38200.eb.